Cochrane, together with a range of other civil society organisations, has written to a group of medicines agencies in Europe asking that they take action to ensure trial transparency.

Reducing the transmission of Coronavirus disease 2019 (COVID-19) is a global priority. Toward this end, public health officials and politicians across the world have been seeking scientific expertise to guide policy. In response, investigators have rushed to share new results on preprint servers, and journals have expedited editorial and peer review processes to publish them.

We are currently only in the office on Tuesdays due to the COVID19 situation in Denmark. Our employees will continue to work from home the other days during the week and can be contacted via email. For any emergencies, you are welcome to contact Asbjørn Hróbjartsson on +45 2479 2553.Best wishes The Cochrane Denmark Team (Updated 26.05.2021)

Professor Asbjørn Hróbjartsson is the new Head of Cochrane Denmark, formerly called the Nordic Cochrane Centre. He is a Professor of Evidence-Based Medicine and Clinical Research Methodology at the University of Southern Denmark, and Head of the Centre for Evidence-Based Medicine Odense (CEBMO).

On the 15th of March 2021 at 14.00 CET, our researcher Asger Paludan-Müller will defend his Ph.D. titled: "When is a randomized trial justified – An analysis of documents submitted to ethics committees".The Ph.D. defence will take place digitally on Zoom and is open for anyone who might be interested. Find more information about the Ph.D. and how to access the defence here:

As of 1st January 2021, Cochrane Nordic will be hosted by the University of Southern Denmark (SDU) in Odense, Denmark and be affiliated with the Centre for Evidence-Based Medicine Odense (CEBMO). With the move to SDU, Cochrane Nordic will become Cochrane Denmark recognizing a change in leadership supported by SDU and implement the new nomenclature system of names for Cochrane geographical centres. Due to this transition period, more details on the future of Cochrane Denmark will be announced later in the year.

In this short interview, our PhD student Camilla Hansen Nejstgaard, who is also based at the Centre for Evidence-Based Medicine Odense (CEBMO) at the University of Southern Denmark tells us about how conflicts of interest may impact on recommendations of drugs and medical devices.

An update to the Cochrane review Physical interventions to interrupt or reduce the spread of respiratory viruses is now available in the Cochrane Library. The review covers findings related to the impact of public health measures including the wearing of masks, handwashing, and physical distancing. (20.11.20)